Co-Authors
This is a "connection" page, showing publications co-authored by SYED WAMIQUE YUSUF and SAAMIR A HASSAN.
Connection Strength
4.056
-
Carcinoid Heart Disease: a Comprehensive Review. Curr Cardiol Rep. 2019 11 19; 21(11):140.
Score: 0.707
-
Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis. Curr Atheroscler Rep. 2018 02 08; 20(2):10.
Score: 0.625
-
Carcinoid heart disease. Heart. 2017 10; 103(19):1488-1495.
Score: 0.596
-
Extensive Painless Aortic Dissection in a Patient With Breast Cancer. Curr Probl Cardiol. 2023 Aug; 48(8):101253.
Score: 0.210
-
Acute coronary syndrome in patients with cancer. Expert Rev Cardiovasc Ther. 2022 Apr; 20(4):275-290.
Score: 0.208
-
Characteristics of infective endocarditis in a cancer population. Open Heart. 2021 08; 8(2).
Score: 0.199
-
Rate of Progression of Aortic Stenosis in Patients With Cancer. Front Cardiovasc Med. 2021; 8:644264.
Score: 0.194
-
Multimodality imaging in carcinoid heart disease. Open Heart. 2019; 6(1):e001060.
Score: 0.171
-
Cardiovascular manifestations of Erdheim-Chester disease. Echocardiography. 2019 02; 36(2):229-236.
Score: 0.166
-
Evolution of echocardiography in subclinical detection of cancer therapy-related cardiac dysfunction. Echocardiography. 2018 06; 35(6):860-868.
Score: 0.159
-
Radiation-Induced Cardiovascular Disease. Curr Atheroscler Rep. 2017 May; 19(5):22.
Score: 0.148
-
Predictors of left ventricular systolic function recovery in the setting of sinus tachycardia in patients with cancer. Echocardiography. 2017 Jan; 34(1):29-36.
Score: 0.143
-
Pericardial disease: a clinical review. Expert Rev Cardiovasc Ther. 2016; 14(4):525-39.
Score: 0.136
-
Cardiac amyloidosis. Expert Rev Cardiovasc Ther. 2014 Feb; 12(2):265-77.
Score: 0.118
-
Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the "forgotten pulmonic valve". Front Cardiovasc Med. 2022; 9:1071138.
Score: 0.055
-
Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis. Front Cardiovasc Med. 2022; 9:916325.
Score: 0.053
-
Speckle-Tracking Echocardiography in Cardio-Oncology and Beyond. Tex Heart Inst J. 2020 04 01; 47(2):96-107.
Score: 0.045
-
Safety of Transesophageal Echocardiography in Patients with Thrombocytopenia. J Am Soc Echocardiogr. 2019 08; 32(8):1010-1015.
Score: 0.043
-
Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol. 2019 04 15; 123(8):1351-1357.
Score: 0.042
-
Echocardiographic measures associated with the presence of left ventricular thrombus in patients with chemotherapy-related cardiac dysfunction. Echocardiography. 2018 10; 35(10):1512-1518.
Score: 0.040